Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITPR3 | Q14573 | 8/20 | 0.94 |
| ▸ | ITPR2 | Q14571 | 4/20 | 0.94 |
| ▸ | ITPR1 | Q14643 | 4/20 | 0.94 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.94 |
| ▸ | AKT1 | P31749 | 1/20 | 0.94 |
| ▸ | INPP5A | Q14642 | 2/20 | 0.84 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ionositol (1,3,4,5,6) P5 SCHEMBL406795 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL29635093 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL29635038 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL29635044 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL2710469 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL15209904 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL406796 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL5159171 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL30469421 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Ionositol (1,3,4,5,6) P5 SCHEMBL357421 | 1.00 | ITPR3 (0.94) | ITPR3ITPR2ITPR1INPPL1AKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8377908-B2 | Fixed-dose association of phytate and zinc | UNIVERSITAT DE LES ILLES BALEARS (ES) | 2013-02-19 | — | — | US | disclosed |
| US-20090035232-A1 | FIXED-DOSE ASSOCIATION OF PHYTATE AND ZINC | UNIVERSITAT DE LES ILLES BALEARS (ES) | 2009-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090035232-A1 | FIXED-DOSE ASSOCIATION OF PHYTATE AND ZINC | SLC30A5, PTH1R, SLC39A7 | ITPR3 68/4885ITPR2 147/4885ITPR1 109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.